Biochemical Effects of Meditation: A Literature Review by Daube, William C & Jakobsche, Charles E
Scholarly Undergraduate Research Journal at Clark
Volume 1 Article 10
October 2015






Follow this and additional works at: https://commons.clarku.edu/surj
Part of the Alternative and Complementary Medicine Commons, and the Biochemistry
Commons
This Review is brought to you for free and open access by the Scholarly Collections & Academic Work at Clark Digital Commons. It has been accepted
for inclusion in Scholarly Undergraduate Research Journal at Clark by an authorized editor of Clark Digital Commons. For more information, please
contact mkrikonis@clarku.edu, jodolan@clarku.edu.
Recommended Citation
Daube, William C. and Jakobsche, Charles E. (2015) "Biochemical Effects of Meditation: A Literature Review," Scholarly




Biochemical Effects of Meditation: A Literature Review
William C. Daube, Charles Jakobsche
William Daube ’15 lives in Medford, Massachusetts and studies Chemistry. His 
research interests include understanding the chemical dynamics and composi-
tion of the troposphere via various types of spectroscopy. He hopes to eventu-
ally pursue graduate studies in either atmospheric chemistry or environmental 
engineering. In his spare time, he participates in Club Basketball and performs 
duties as the President of CUBS (Big Brothers Big Sisters).
Abstract
Meditation is an activity that can help reduce stress and anxiety from daily life as well as help cultivate overall feel-
ings of peacefulness, relaxation, and contentment. This review describes several studies that have been used to assess 
how meditation can influence the body at the molecular level. The presented results focus on small-molecule metab-
olites, which are broadly defined as naturally-produced molecules that weigh less than approximately 1000 Da. The 
results show that meditation can significantly affect hormones and neurotransmitters such as cortisol, dehydroepi-
androstrone, serotonin, melatonin, and epinephrine. Some common and modern experimental techniques that are 
relevant to these studies are also discussed, as well as some challenges of accurately interpreting the results. Overall, 
understanding the molecular-level effects of meditation can provide a more detailed understanding of its physiologi-
cal effects because many of the affected molecules are known to be linked to changes in stress responses and mood.
Meditation Overview
 Meditation is known for its 
ability to help relax and de-stress 
the mind and body. While there 
are many different approaches to 
meditation, including transcendental 
meditation, Buddhist and Dham-
makaya meditation, mindfulness-
based stress reduction, progressive 
muscle relaxation, and multiple 
types of yoga, some common core 
ideas include focusing on the pres-
ent moment, being aware of one’s 
self and one’s surroundings, clear-
ing one’s mind from distractions, 
and purposefully controlling one’s 
breath and physical movements. As 
an example of a common practice, 
a typical transcendental meditator 
would spend 15–20 minutes in the 
morning and again in the evening, 
seated with eyes closed and mentally 
focusing on silently repeating a word 
or phrase to calm the mind and 
reduce mental distractions. 
 Practicing meditation can 
promote physiological responses in 
the body such as decreased blood 
pressure and reduced breathing rate. 
Pioneering work by Herbert Benson 
described these effects as the “relax-
ation response,” which is produced 
by activation of the parasympathetic 
nervous system.1 The relaxation 
response is opposite to the more 
commonly known “fight-or-flight 
response,” which is produced by the 
activation of the sympathetic ner-
vous system.2 The content of this re-
view focuses on specific biochemical 
changes at the molecular level that 
can result from practicing medita-
tion.
Analytical Techniques
 Experimental techniques for 
analyzing concentrations of biologi-
cal chemicals involve two general 
stages: first, acquiring a biological 
sample from the subject and then, 
measuring the concentration of a 
molecule of interest. Some com-
pounds can be measured from saliva 
or urine samples, which are relatively 
simple to acquire. However, other 
compounds are best measured from 
blood serum or plasma samples, 
which must be obtained by trained 
experts. Additionally, needles are of-
ten inserted hours before the experi-
ment in order to produce data that is 
not affected by any short-term stress 
effects from the puncture. Some 
metabolites can be quantified by 
simple gas chromatography or high-
pressure liquid chromatography, 
but in many cases more complex 
assays are required. One common 
assay for measuring the usually very 
small concentration of metabolites 
in serum is a radioimmunoassay. In 




with a known concentration of a 
synthetic version of the metabolite 
that has been made to contain a
radioactive atom (for example 125I). 
The isolated, non-radioactive metab-
olite and the synthetic, radioactive 
one compete to bind to immobilized 
antibodies. After washing away the 
unbound molecules, the amount 
of radioactivity produced by the 
antibody-bound metabolites can be 
compared to a standardized curve 
in order to calculate the original 
concentration of the isolated me-
tabolite. A second useful technique 
in an enzyme-linked immunosor-
bent assay (ELISA), which also uses 
immobilized antibodies to bind the 
isolated metabolite, but then uses 
enzyme-catalyzed generation of color 
or fluorescence as a readout instead 
of radioactivity.  
 Regardless of which bio-
chemistry technique is used, the de-
tails of the experimental procedures 
that relate to the human subjects 
must also be carefully planned. 
Many metabolites undergo natural 
changes in concentration through-
out the day, and others are affected 
by eating particular foods, smoking, 
or other daily activities. Age and 
gender can also significantly affect 
some metabolites. While no two 
people or two situations will provide 
a perfectly matched negative-control 
experiment for a test condition, 
having a stronger understanding of 
the metabolites of interest enables 
experiment designers to create bet-
ter control groups. For experiments 
assessing the immediate effects of 
meditation, experiment design-
ers must decide what the control 
subjects should do while the test 
group is meditating; sitting, relax-
ing, keeping eyes open or closed, 
conversing, or watching TV are all 
options that can be  considered. For 
experiments assessing the long term 
effects of regular meditation, it can 
be difficult to isolate the effects of 
meditation versus effects that result 
from other lifestyle choices (diet, for 
example) that may be more common 
in meditators versus non-meditators. 
In all cases it is important to have 
large enough sample sizes so that 
appropriate statistical analyses can 
be used to validate the significance 
of any observed differences. To show 
the statistical significance of the 
experimental results described in this 
review, respective p-values are in-
cluded, which indicate the probabil-
ity of such strong correlations being 
randomly produced if the underlying 
hypotheses were not true.
Metabolites and Biomarkers
 Among the metabolites af-
fected by meditation, the hormone 
cortisol (Figure 1) is perhaps the best 
studied. Physical and psychological 
stress cause the body to increase its 
cortisol levels. Cortisol molecules 
travel throughout the body to 
activate various biological responses 
intended to improve the body’s 
short-term performance in stressful 
situations, which is often called “the 
fight or flight response”.3 Biological 
effects of increased cortisol include 
increased blood pressure, blood sugar 
levels, and metabolism, which pro-
vides an extra boost of energy and 
suppression of the immune system, 
to divert energy towards the more 
immediate need. Chronic stress and 
long term elevation of cortisol cause 
the body to remain in this activated 
state and are associated with nu-
merous diseases.4 Thus, cortisol is 
generally considered a biochemical 
indicator of stress and a risk factor 
for associated medical conditions.
 In one study, Jevning and 
coworkers report that the average 
plasma concentration of cortisol in a 
group of fifteen experienced tran-
scendental meditators decreased by 
a statistically significant (p < 0.01) 
27% after a 30-minute meditation 
session.5 In contrast, a group of 
fifteen control subjects untrained in 
meditation, who were simply al-
lowed to rest instead of meditating, 
did not show a statistically signifi-
cant change. As a follow-up ex-
periment, the control subjects were 
trained in transcendental medita-
tion and retested after three to four 
months of practice. After thirty min-
utes of meditation, this group did 
show a decrease in average cortisol 
but it was not as large of a decrease 
as the experienced meditators had 
produced (p < 0.3). All three groups 
(experienced meditators, controls, 
and controls after training) showed 
similar levels of cortisol in the time 
period before meditating or resting.
 In a second study, Sudsuang 
and coworkers reported that after 
a six-week training period in Bud-
dhist meditation, and meditating 
immediately prior to testing, a group 
of fifteen Thai boys age twenty to 
twenty-five showed an average 24% 
reduction (p < 0.01) in serum cor-
tisol levels compared to their levels 
before the training began.6 A control 
group of thirty boys who stayed 
home on vacation instead of being 
trained showed no significant change 
in cortisol. Interestingly, a group of 
twenty-seven boys who were trained, 
but described themselves as not be-
ing able to find tranquility during 
the meditation, also did not show 
any significant change in cortisol 
levels. Together these results not only 
suggest that meditation can help 
reduce stress by lowering cortisol lev-
els, but also that successful medita-
tion is more than simply resting the 
body and is a mental skill that can 






(DHEA) and its sulfate ester 
(DHEAS) are hormones that are 
abundant in the human body and 
serve as the biological precursor for 
other steroid-type hormones in-
cluding testosterone and estrogen. 
Although DHEA and cortisol are 
similar in chemical structure and 
both made from cholesterol via 
several steps, their biological effects 
are completely different. Much inter-
est in DHEA relates to its observed 
decrease with age and potential ap-
plications as “anti-aging” treatments 
for memory-loss, low-REM sleep, or 
skin issues.7
  DHEAS levels have been 
reported to correlate with medita-
tion activity. In a large scale study, 
Glazer and coworkers measured 
DHEAS’s serum concentration in 
423 people who regularly practiced 
transcendental meditation and 1252 
people who did not.8 Higher average 
levels of DHEAS were observed in 
the meditators groups for both men 
(p = 0.001) and women (p < 0.001). 
Women showed increases, mostly in 
the 17–54% range, for every age 
group studied (20–74 years old) and
men showed increases in most older 
age groups (45 to over 70 years old). 
The authors note that while it is pos-
sible that other lifestyle differences 
between the meditator and non-
meditator groups may be responsible 
for the differences in DHEAS, their 
results suggest that neither diet, 
smoking, nor alcohol consump-
tion directly caused the observed 
differences in DHEAS. Currently, 
not enough is known to specifically 
define how or if higher levels of 
DHEAS may directly, or indirectly 
through modifying testosterone, 
estrogen, or cortisol levels, relate to 
improved health or youthful vigor.
 Serotonin acts as a neu-
rotransmitter in the central nervous 
system and is also involved in the 
digestive tract. It helps regulate 
physiological mechanisms such as 
maintaining body temperature, 
motor control, circadian rhythms, 
and also affects mood by producing 
a general sense of satisfaction and 
relaxation.9 Feelings of depression 
and anxiety are often associated with 
low serotonin levels, and several an-
tidepressant drugs including Prozac 
function by increasing serotonin-
based biological pathways.10 
Serotonin is naturally metabolized 
into 5-hydroxyindole-3-acetic acid 
(5-HIAA) before being excreted, so 
5-HIAA concentrations can serve 
as indicators of serotonin levels. In 
one experiment, Bujatti & Riederer 
analyzed urine concentrations of 
5-HIAA in eleven subjects who regu-
larly practiced transcendental medi-
tation compared to fifteen healthy 
control subjects.11
  At the beginning of the test, 
the meditators already showed more 
than twice the average concentration 
of 5-HIAA compared to the control 
group (p = 0.01) and after thirty 
minutes of meditation, the medita-
tor’s 5HIAA levels rose to more than 
triple that of the control subjects (p 
= 0.005) who had spent the thirty 
minutes engaged in light activity and 
conversation, and whose 5-HIAA 
levels had not significantly changed. 
In another experiment, Walton and 
coworkers compared urine samples 
from twenty-two college students 
who regularly practice transcenden-
tal meditation to thirty-three control 
students.12 Analysis of urine excreted 
during the night and early morning 
showed approximately 70% higher 
average concentrations of 5-HIAA 
in the meditators compared to the 
control subjects (p < 0.015). To-
gether these results not only sug-
gest that meditation can increase 
serotonin levels, but that these levels 
can remain elevated throughout 
the day and night. Serotonin has 
been called the “rest and fulfillment 
hormone,”11 and it seems possible 
that its effects could contribute to a 
general sense of happiness in those 
who meditate regularly. This hypoth-
esis is supported by a study by Yu 
and coworkers that used a qualita-
tive assessment of mood-states to 




identify mood changes in a group of 
fifteen individuals following a twenty 
minute session of focused-attention 
breathing meditation.13 After medi-
tation, the subjects showed reduced 
average scores for tension and 
anxiety (p < 0.01), depression (p 
< 0.001), anger and hostility (p < 
0.05). 
 The hormone melatonin 
plays an important role in regulating 
the sleeping–waking cycle.14 Melato-
nin levels increase in the evening and 
night as it is synthesized from sero-
tonin. Interestingly, the biosynthesis 
of melatonin is inhibited by strong 
light, presumably to help match the 
sleeping–waking cycle with the natu-
ral day–night cycle. In addition to 
promoting sleep, melatonin’s biologi-
cal effects include depression of the 
central nervous system, reduction 
of pain sensitivity, upregulation of 
the immune system, and promotion 
of general feelings of happiness.15 
Some anti-insomnia drugs function 
by increasing melatonin pathways. 
Melatonin has also been shown to 
suppress the growth of some types of 
cancer.16,17
 In one study, Tooley and co-
workers have reported that after per-
forming transcendental meditation–
Sidhi for sixty minutes in the late 
evening, a group of ten meditators 
showed an average plasma concen-
tration of melatonin that was 22% 
higher (p < 0.01) than was observed 
in the same subjects on a different 
night after they sat quietly without 
meditating. The groups did not show 
any difference in melatonin concen-
tration before meditating and half 
the group acted as the control group 
on each night. The authors note that 
ambient lighting levels were main-
tained substantially below the in-
tensities that are known to influence 
melatonin production. The results of 
this experiment suggest that meditat-
ing before going to sleep may help 
the body transition into sleep and 
enhance the many known benefits 
of sleeping well. Indeed, Brand 
and coworkers have reported that a 
group of nine experienced medita-
tors scored substantially better on 
a qualitative sleep-quality index (p 
= 0.02) than did a control group of 
eleven novices.19 After eight weeks of 
training in mindfulness-based stress 
reduction meditation, the novices’ 
sleep-quality scores improved (p = 
0.008), but not to the levels scored 
by the long-term meditators. 
 Epinephrine (also called 
adrenaline) and norepinephrine are 
two related hormones that are as-
sociated with biological responses to 
fear and physical exertion.20 These 
molecules temporarily produce high 
levels of alertness, which could help 
a person survive a dangerous situ-
ation. Epinephrine increases heart 
rate, respiratory rate, blood pressure, 
and metabolism. Norepinephrine 
increases heart rate, serves as a neu-
rotransmitter in areas of the brain 
associated with alertness, and is the 
biological precursor for the synthesis 
of epinephrine.
 In one experiment, Infante 
and coworkers compared the plasma 
concentrations of epinephrine and 
norepinephrine of nineteen regular 
practitioners of transcendental medi-
tation versus sixteen healthy control 
subjects.21 Average morning concen-
trations of epinephrine and nor-
epinephrine in the meditators were 
approximately 30% lower (p < 0.01) 
and 40% lower (p < 0.01) respective-
ly than those in the control subjects. 
Epinephrine and norepinephrine 
levels can also be measured by 
measuring urine concentrations of 
vanillylmandelic acid (VMA), which 
is a metabolic product of each. Bu-
jatti & Riederer’s experiment showed 
that both before and after a  thirty 
minute session of meditation, or 
light activity for the control group, 
a group of regular meditators had 
VMA concentrations approximately 
50% lower than those measured 
for control subjects (p = 0.025). 
Conversely, Walton and coworkers’ 
experiment 12 suggests that elevated 
VMA levels can be more substantial-
ly influenced by high sodium intake 
(62% increase, p = 0.002) than by 
regular meditation (21% decrease, 
p = 0.1). While these studies high-
light the importance of comparing 
meditators to well-matched control 
groups, the overall results do suggest 
that people who regularly meditate 
can maintain lower levels of adrena-
line and thereby maintain a more 
relaxed mindset.
Connecting the Pieces
 Although studying indi-
vidual metabolites one by one can 
identify specific biochemical ef-
fects of meditation, the data must 
be integrated together to produce a 
broader understanding of the over-
all effects. Elias and coworkers have 
hypothesized that during medita-
tion the body switches from glucose 
metabolism to fatty acid metabolism 
and that the altered concentration 
of product molecules being pro-
duced may lead to increased produc-
tion of gamma-aminobutyric acid 
(GABA) in the brain.22,23 GABA is 
an inhibitory neurotransmitter and 
its increase can relax the mind. In 
one study, Guglietti and coworkers 
used transcranial magnetic stimula-
tion to analyze brain activity before 
and after a sixty minute medita-
tion session.24 A group of thirty-five 
people who meditated showed a 
10% increase (p = 0.02) in average 
cortical-silent period, which is a 
measurement used to evaluate overall 





 A control group of thirty-
five people who watched television 
instead of meditating showed no 
change in their average cortical silent 
period. In a study that measured 
GABA directly, Streeter and cowork-
ers reported that practicing yoga 
can elevate GABA levels,25 which is 
relevant to meditation because the 
similarities between the mental re-
laxation achieved through yoga and 
through meditation are well known. 
Some physiological responses pro-
duced by fasting are also similar to 
those produced by meditation, and 
Jevning and coworkers note that fast-
ing also produces a shift away from 
glucose and towards fatty acids as the 
primary energy source.26 Thus, it is 
possible that during meditation it is 
the combination of reduced muscle 
activity and reduced mental activity 
that causes a reduced energy demand 
that enables the biological shift away 
from glucose-based metabolism and 
towards a more restorative body 
state.
New Experimental Directions
 A newer field of research that 
has been gaining interest in recent 
years is the area of metabolomics.27 
Similar to genetics (which studies 
genes) or proteomics (which stud-
ies proteins), metabolomics aims to 
simultaneously study all the small-
molecule metabolites in a given 
biological system by identifying 
which metabolites are affected by a 
particular experimental condition, 
for example. To provide sufficient 
resolution to deconvolute mixtures 
of many molecules, experimental 
techniques often involve multidi-
mensional analysis. Some techniques 
include LC-MS-MS, which is high 
performance liquid chromatog-
raphy feeding directly into mass 
spectrometry separation followed 
by mass spectrometry analysis, or 
multidimensional NMR, nuclear 
magnetic resonance. While various 
databases containing information on 
over 40,000 human metabolites have 
been established, we are unaware 
of any studies that have utilized a 
metabolomics approach to further 




 The mind has an incredible 
amount of control over the body. 
Beyond conscious movements of 
skeletal muscles, a person’s mental 
state can influence subconscious 
body functions such as heart rate, 
blood pressure, and even the pro-
duction of biochemical molecules. 
A substantial amount of scientific 
research has shown that meditation 
can influence the biological con-
centrations of a number of human 
hormones and neurotransmitters, 
many of which are known to be 
linked to biological control of stress 
and mood. These findings correlate  
well with the well-known positive in-
fluences of meditation on relaxation 
and contentment. One challenge 
of meditation research is setting up 
appropriate negative-control groups 
to enable specific comparisons to be 
made and to identify the specific ef-
fects of meditation on biochemistry. 
Other challenges include running 
these experiments on a large enough 
scale to provide statistically valid re-
sults and identifying enough affected 
metabolites to be able to provide 
a complete understanding of the 
biochemical impacts of meditation. 
Interestingly, many of the biochemi-
cal pathways that can be affected by 
meditation have also served as the 
biological targets of medical drugs 
developed to treat a variety of mental 
and physical symptoms. Thus, we 
believe that meditation, as well as 
other healthy-living habits, may have 
the potential to serve as a drug-free 
approach to treating or preemptively 
reducing a variety of stress-related 
conditions and depressive mood 
disorders that have become all too 
common in modern society.
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